---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-26-000080"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2026-06-01T20:32:30+00:00"
generated_at: "2026-06-01T20:44:47.660365+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair

## Summary
- Michel Lagarde appointed President & CEO of West Pharmaceutical, effective Aug 31, 2026.
- Eric Green retires as President, CEO and Board Chair; Robert F. Friel becomes Board Chair.
- Employment agreement: $1,175,000 base salary; target annual incentive 125% of base; 2026 LTI grant valued at $8,611,111.
- Lagarde receives inducement equity awards up to $10M, including sign-on grant of $6,875,000 and matching RSUs/options.
- Lagarde previously served as EVP & COO at Thermo Fisher Scientific; holds BBA from European University Antwerp.

## SEC filing metadata
- accession: 0000105770-26-000080
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2026-06-01T20:32:30+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-26-000080
- JSON: https://secwatch.observer/filing/0000105770-26-000080.json
- Plain text: https://secwatch.observer/filing/0000105770-26-000080.txt

## Source-grounded claims
- claim_id: 110df09076
  claim: Michel Lagarde was appointed as member of the Board at WEST PHARMACEUTICAL SERVICES INC.
  evidence_excerpt: As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm
- claim_id: 489de7d690
  claim: Eric M. Green resigned as member of the Board at WEST PHARMACEUTICAL SERVICES INC.
  evidence_excerpt: As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm
- claim_id: ed4efa369b
  claim: Michel Lagarde was appointed as President and Chief Executive Officer at WEST PHARMACEUTICAL SERVICES INC.
  evidence_excerpt: On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the “Start Date”), to replace Mr. Green in those roles.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm
- claim_id: f71bb330ff
  claim: Robert F. Friel was appointed as Chair of the Board at WEST PHARMACEUTICAL SERVICES INC.
  evidence_excerpt: As of the Start Date, Lead Independent Director Robert F. Friel will become Chair of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.